Development and Evaluation of a Rapid CRISPR-based Diagnostic for COVID-19.

Tieying Hou,Weiqi Zeng,Minling Yang,Wenjing Chen,Lili Ren,Jingwen Ai,Ji Wu,Yalong Liao,Xuejing Gou,Yongjun Li,Xiaorui Wang,Hang Su,Bing Gu,Jianwei Wang,Teng Xu
DOI: https://doi.org/10.1371/journal.ppat.1008705
IF: 7.464
2020-01-01
PLoS Pathogens
Abstract:The recent outbreak of human infections caused by SARS-CoV-2, the third zoonotic coronavirus has raised great public health concern globally. Rapid and accurate diagnosis of this novel pathogen posts great challenges not only clinically but also technologically. Metagenomic next-generation sequencing (mNGS) and reverse-transcription PCR (RT-PCR) have been the most commonly used molecular methodologies. However, each has their own limitations. In this study, we developed an isothermal, CRISPR-based diagnostic for COVID-19 with near single-copy sensitivity. The diagnostic performances of all three technology platforms were also compared. Our study aimed to provide more insights into the molecular detection of SARS-CoV-2, and also to present a novel diagnostic option for this new emerging virus.
What problem does this paper attempt to address?